Scientist Breeds Gene-Edited Beagle to Combat Pet Allergies

A New York-based geneticist, Dr. Matt Walker, has successfully employed CRISPR gene-editing technology to breed a beagle puppy named Bailey that does not trigger his severe pet allergies. This breakthrough involves deactivating a specific gene responsible for producing allergy-causing proteins in the dog's saliva and hair.

Dr. Walker, who has a lifelong passion for dogs but was unable to own one due to his allergies, can now interact with Bailey without experiencing symptoms. The technique used CRISPR, a Nobel Prize-winning gene-editing tool that allows for precise modifications to DNA. Scientists deactivated the gene responsible for the primary allergy-causing protein in dog DNA, then used this edited DNA to create embryos that were implanted into a surrogate beagle mother. In 2024, this resulted in the birth of Bailey and her twin brother, Alfie, who are genetically engineered to be hypoallergenic.

Initial tests, including allergy prick tests comparing samples from Bailey, Alfie, and other dog breeds, showed no allergic reaction to the gene-edited beagles, unlike the reactions observed with samples from a Poodle and a Goldendoodle. "The feeling right now is sort of a mix of relief and awe and gratitude that it worked," Dr. Walker stated. "It feels just amazing to get to have a dog."

While this development offers hope for millions of people with pet allergies, it will be years before such dogs are widely available. Kindred Companion Sciences, Dr. Walker's company, plans to continue monitoring Bailey and Alfie for any unintended health effects of the genetic modifications. The company also aims to replicate this process with other dog breeds to create an entire line of allergy-free puppies.

Professor Arthur Caplan, a bioethicist at New York University's Grossman School of Medicine, noted that this advancement "opens the door to a lot more people being able to own pets." However, experts also raise concerns that the availability of hypoallergenic dogs might inadvertently discourage the adoption of unmodified shelter animals.

Further research is required to confirm the long-term effectiveness and broad applicability of this gene edit for all individuals with dog allergies. Dr. Jeff SoRelle, a pathologist at the University of Texas Southwestern Medical Center, emphasized the need for more extensive testing on a larger group of people with varying allergies to fully understand the potential of these allergy-free dogs. Scientists will continue to monitor the health of Bailey and Alfie during routine veterinary visits.